
Northwestern University Feinberg School of Medicine has been selected to serve as the home of the Journal of Clinical Investigation for its next five-year term, and Elizabeth McNally, MD, PhD, has been elected as the journal’s next editor-in-chief.

Follow along with a typical day in the life of third-year Feinberg medical student, as he spends a shift in the OB-GYN ward, including assisting with a delivery.

A new study has shown that the degeneration of brain motor neurons in ALS is not merely a byproduct of the spinal motor neuron degeneration, and is a target for future treatments for the disease.

David Cella, PhD, the Ralph Seal Paffenbarger Professor, has announced that he will be stepping down as chair of the Department of Medical Social Sciences, the department he helped establish in 2009.

Northwestern Medicine scientists have discovered a new biomarker to identify which patients with brain tumors called glioblastomas — the most common and malignant of primary brain tumors — might benefit from immunotherapy.

Neurodegenerative Disease Research Inc. has made a five-year, $12.5 million philanthropic commitment to Northwestern to support research in amyotrophic lateral sclerosis (ALS) led by Teepu Siddique, MD.

Northwestern University Feinberg School of Medicine has been awarded a $550,000 grant to support the retention of early-career clinician investigators experiencing family caregiving challenges due to the COVID-19 pandemic.

A recent study identified a gene that is critical for daily behavioral rhythms, involved in a molecular pathway by which the core circadian clock controls daily sleep-wake cycles.

Ann & Robert H. Lurie Children’s Hospital of Chicago has recruited an internationally recognized surgeon-scientist, Thomas H. Inge, MD, PhD, as the hospital’s next surgeon-in-chief.

A new injectable therapy harnesses “dancing molecules” to reverse paralysis and repair tissue after severe spinal cord injuries, allowing animal subjects to regain the ability to walk.